After propensity score matching analysis (66 vs. 66), SS II PCI and CABG were significantly higher in patients with CAS than those without CAS 37.4 (30.9-43.5) vs. 33 (29.3-36.9); P=0.03. SS I was similar between groups. Age was significantly higher in patients with CAS. Characteristics of the population before and after matching are presented in Table 1.
In the matched population, age, SS II PCI and CABG were associated with CAS in univariate logistic regression analysis OR=1.086, 95% CI (1.032-1.143), P<0.001; OR=1.054, 95% CI (1.010-1.101), P=0.02; OR=1.078, 95% CI (1.029-1.129), P<0.01. The results of univariate analysis are listed in Table 2.
[ Table Omitted - see PDF ]
DISCUSSION
Approximately 16% of the patients in our study had significant CAS. The present study demonstrated increased SS II PCI and CABG score in patients with CAS compared to those without CAS by means of propensity score matched analysis. SS II is associated with significant CAS in a population with multivessel disease. SS II CABG had a better diagnostic accuracy, albeit not statistically significant. SS I was not found to be associated with CAS.
Carotid intima-media thickness (CIMT) was shown to be associated with cardiovascular mortality. Several studies demonstrated a close association between CIMT and SS I9-11. A recent study showed that CIMT correlated with SS II12. Two previous studies concluded that SS I is not a predictor of CAS13,14. Compatible with these studies, SS I was not associated with CAS whereas age was an independent predictor of CAS in our study14. A latter study by the same group of researchers confirmed a relationship between SS II and CAS15. A recent study by Avci et al.13 demonstrated the association between SS I and CAS, however, this association was not independent. As argued in various studies, SS is a weighted score taking into account anatomical properties such as tortuosity and calcification, in addition to atherosclerotic lesions. Thus, SS I may be less powerful than Gensini score to predict atherosclerotic burden. Therefore, extent of coronary atherosclerosis may not be thoroughly represented with SS I.
A recent study found CAS as an independent predictor of high SYNTAX score (>32), however, the study population was heterogeneous and comprised patients with single and multivessel disease16. Up to date, only a single study investigated the relationship between SS II and CAS15. Baseline characteristics and risk factors of patients in this study were similar to ours. Age was the most important risk factor for CAS in both studies. SS I only reflects anatomical complexity of coronary artery disease. Recently, SS II incorporates clinical factors such as age, sex, and eGFR, in addition to SS I. However, we think high SS II in our study seems to be more related to age and peripheral arterial disease (PAD) rather than other variables in the scoring system, since they are not associated with CAS in the regression analysis. Apart from the previous studies, we used propensity score matching in order to balance patient characteristics. Nevertheless, CAS seems to be more related to age rather than the complexity of coronary atherosclerosis and clinical risk factors in patients with multivessel disease.
Limitations
The relatively small number of patients and the retrospective nature of the study are major limitations. Since Doppler ultrasound was performed before surgery with the intention to identify critical CAS, CIMT, which may have a further contribution, was not evaluated. Subjects enrolled in our study have multivessel disease and most patients had intermediate to high SS scores. This restriction causes a limitation to generalize the study. Thus, our findings are valid for a restricted patient group.
CONCLUSION
SS I is not associated with significant carotid artery stenosis. SS II is useful to predict carotid artery stenosis in patients with multivessel coronary artery disease.
This study was carried out at Haseki Training and Research Hospital, Istanbul, Turkey.
No financial support.
1 Imori Y, Akasaka T, Ochiai T, Oyama K, Tobita K, Shishido K, et al. Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease. Am J Cardiol. 2014;113(1):30-5. doi:10.1016/j.amjcard.2013.09.015.
2 Steinvil A, Sadeh B, Arbel Y, Justo D, Belei A, Borenstein N, et al. Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol. 2011;57(7):779-83. doi:10.1016/j.jacc.2010.09.047.
3 Podolecka E, Wanha W, Michalewska-Wludarczyk A, Wludarczyk W, Bachowski R, Deja M, et al. Effect of a significant asymptomatic unilateral carotid artery stenosis on outcomes in patients undergoing coronary artery bypass grafting. Kardiol Pol. 2014;72(10):954-9. doi:10.5603/KP.a2014.0113.
4 Narayan P, Khan MW, Das D, Guha Biswas R, Das M, Rupert E. Carotid artery screening at the time of coronary artery bypass - Does it influence neurological outcomes? Int J Cardiol. 2017;243:140-4. doi:10.1016/j.ijcard.2017.05.082.
5 Bundhun PK, Bhurtu A, Huang F. Worse clinical outcomes following percutaneous coronary intervention with a high SYNTAX score: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(24):e7140. doi:10.1097/MD.0000000000007140.
6 Cavalcante R, Sotomi Y, Mancone M, Whan Lee C, Ahn JM, Onuma Y, et al. Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials. Eur Heart J. 2017;38(25):1969-77. doi:10.1093/eurheartj/ehx138.
7 Brener SJ, Alapati V, Chan D, Da-Wariboko A, Kaid Y, Latyshev Y, et al. The SYNTAX II score predicts mortality at 4 years in patients undergoing percutaneous coronary intervention. J Invasive Cardiol. 2018;30(8):290-4.
8 He J, Zhao H, Yu X, Li Q, Lv S, Chen F, et al. SYNTAX Score-II predicts long-term mortality in patients who underwent left main percutaneous coronary intervention treated with second-generation drug-eluting stents. Int Heart J. 2017;58(3):344-50. doi:10.1536/ihj.16-292.
9 Korkmaz L, Bektas H, Korkmaz AA, Agaç MT, Acar Z, Erkan H, et al. Increased carotid intima-media thickness is associated with higher SYNTAX score. Angiology. 2012;63(5):386-9. doi:10.1177/0003319711419837.
10 Saedi S, Ghadrdoost B2, Pouraliakbar H, Zahedmehr A, Jebelli A. The association between increased carotid intima-media thickness and SYNTAX Score in coronary artery disease: A single center study. Indian Heart J. 2018;70(5):627-9. doi:10.1016/j.ihj.2018.01.010.
11 Ikeda N, Gupta A, Dey N, Bose S, Shafique S, Arak T, et al. Improved correlation between carotid and coronary atherosclerosis SYNTAX score using automated ultrasound carotid bulb plaque IMT measurement. Ultrasound Med Biol. 2015;41(5):1247-62. doi:10.1016/j.ultrasmedbio.2014.12.024.
12 Aksu U, Gulcu O, Bilgi Z, Topcu S, Sevimli S, Bayram E, et al. The association of the syntax score II with carotid intima media thickness and epicardial fat tissue. Indian Heart J. 2017;69(6):752-6. doi:10.1016/j.ihj.2017.04.008.
13 Avci A, Fidan S, Tabakçı MM, Toprak C, Alizade E, Acar E, et al. Association between the gensini score and carotid artery stenosis. Korean Circ J. 2016;46(5):639-45. doi:10.4070/kcj.2016.46.5.639.
14 Costanzo L, Campisano MB, Capodanno D, Sole A, Grasso C, Ragusa M, et al. The SYNTAX score does not predict presence of carotid disease in a multivessel coronary disease population. Catheter Cardiovasc Interv. 2014;83(7):1169-75. doi:10.1002/ccd.25320.
15 Costanzo L, Capodanno D, Manichino D, Sole A, Ronsivalle G, Di Pino L, et al. SYNTAX score II predicts carotid disease in a multivessel coronary disease population. Int J Cardiol. 2015;196:145-8. doi:10.1016/j.ijcard.2015.06.005.
16 Cappelletti A, Astore D, Godino C, Bellini B, Magni V, Mazzavillani M, et al. Relationship between syntax score and prognostic localization of coronary artery lesions with conventional risk factors, plasma profile markers,and carotid atherosclerosis (CAPP Study 2). Int J Cardiol. 2018;257:306-11. doi:10.1016/j.ijcard.2017.12.012.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2019. This work is published under https://creativecommons.org/licenses/by/4.0/deed.en (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
[...]SS I may be less powerful than Gensini score to predict atherosclerotic burden. [...]extent of coronary atherosclerosis may not be thoroughly represented with SS I. A recent study found CAS as an independent predictor of high SYNTAX score (>32), however, the study population was heterogeneous and comprised patients with single and multivessel disease16. Limitations The relatively small number of patients and the retrospective nature of the study are major limitations. Since Doppler ultrasound was performed before surgery with the intention to identify critical CAS, CIMT, which may have a further contribution, was not evaluated. [...]our findings are valid for a restricted patient group.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer